Pfizer Inc.

NYSE-PFE

OverviewFinancialsInvestor RelationsResearchEstimatesNewsOwnershipIndustryDividendsModelingFilings

Assets	LTM	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
Cash and Cash Equivalents	1,343	1,043	2,853	416	1,944	1,786	1,121	1,139	1,342	2,595	3,641
Cash and Cash Equivalents
Short-Term Investments	13,641	19,434	9,837	22,316	29,125	10,437	8,525	17,694	18,650	15,255	19,649
Short-Term Investments
Total Cash and Cash Equivalents	14,984	20,477	12,690	22,732	31,069	12,223	9,646	18,833	19,992	17,850	23,290
Accounts Receivable	14,260	11,463	11,566	10,952	11,479	7,913	6,772	8,025	8,221	8,225	8,176
Trade Accounts Receivable, Net of Allowance for Doubtful Accounts
Total Trade Receivables	14,260	11,463	11,566	10,952	11,479	7,913	6,772	8,025	8,221	8,225	8,176
Inventories	11,468	10,851	10,189	8,981	9,059	8,020	7,068	7,508	7,578	6,783	7,513
Inventories
Other Current Assets	6,213	7,567	8,889	8,594	8,086	6,910	9,317	15,560	5,351	6,091	4,825
Current Deferred Tax Assets and Other Current Tax Assets
Current Tax Assets
Other Current Assets
Assets Held for Sale
Current Assets of Discontinued Operations and Other Assets Held for Sale
Total Current Assets	46,924	50,358	43,333	51,259	59,693	35,067	32,803	49,926	41,141	38,949	43,804
Total Current Assets
Net Property, Plant & Equipment	18,880	18,393	18,940	16,274	14,882	13,745	12,969	13,385	13,865	13,318	13,766
Property, Plant and Equipment, Net of Accumulated Depreciation
Net Intangible Assets	51,324	55,411	64,900	43,370	25,146	28,337	33,936	35,211	48,741	52,648	40,356
Identifiable Intangible Assets, Net
Goodwill	69,101	68,527	67,783	51,375	49,208	49,556	48,202	53,411	55,952	54,449	48,242
Goodwill
Long-Term Investments	2,137	2,228	15,368	15,069	21,526	20,262	20,147	2,767	7,015	7,116	15,999
Equity-Method Investments
Long-Term Investments
Other Long-Term Assets	20,365	18,479	16,177	19,856	11,020	7,262	19,537	4,723	5,082	5,135	5,214
Taxes and Other Noncurrent Assets
Noncurrent Deferred Tax Assets and Other Noncurrent Tax Assets
Other Noncurrent Assets
Noncurrent Assets of Discontinued Operations
Total Assets	208,731	213,396	226,501	197,205	181,476	154,229	167,594	159,422	171,797	171,615	167,381
Total Assets

Liabilities	LTM	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
Accounts Payable	5,024	5,633	6,710	6,809	5,578	4,283	3,887	4,674	4,656	4,536	3,620
Accounts Payable
Trade Accounts Payable
Accrued Expenses	3,036	3,838	2,776	3,407	3,332	3,049	2,390	2,397	2,196	2,487	2,359
Accrued Compensation and Related Items
Short-Term Debt	4,303	6,946	10,350	2,945	2,241	2,703	16,195	8,831	9,953	10,688	10,159
Short-Term Borrowings, Including Current Portion of Long-Term Debt
Unearned Revenue	924	1,511	2,700	2,520	3,067	1,113	—	—	—	—	—
Deferred Revenues
Other Current Liabilities	23,308	25,067	25,258	26,458	28,454	14,772	14,831	15,955	13,621	13,404	13,260
Dividends Payable
Income Taxes Payable
Other Current Liabilities
Current Liabilities of Discontinued Operations
Total Current Liabilities	36,596	42,995	47,794	42,138	42,671	25,920	37,304	31,858	30,427	31,115	29,399
Total Current Liabilities
Long-Term Debt	57,409	57,405	61,538	32,884	36,195	37,133	35,955	32,909	33,538	31,398	28,740
Long-Term Debt
Other Long-Term Liabilities	21,630	24,499	27,880	26,265	25,147	27,703	30,889	30,897	36,176	49,262	44,245
Pension Benefit Obligations
Postretirement Benefit Obligations
Pension and Postretirement Benefit Obligations
Postretirement Benefit Obligations, Net
Noncurrent Deferred Tax Liabilities
Other Taxes Payable
Other Noncurrent Liabilities
Total Long-Term Liabilities	79,039	81,904	89,418	59,149	61,342	64,836	66,844	63,806	69,714	80,660	72,985
Total Liabilities	115,635	124,899	137,213	101,288	104,013	90,756	104,148	95,664	100,141	111,776	102,384
Total Liabilities

Equity	LTM	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
Preferred Stock	—	—	—	—	—	—	17	19	21	24	26
Preferred Stock, No Par Value, at Stated Value
Common Stock	481	480	478	476	473	470	468	467	464	461	459
Common Stock
Treasury Stock	-115,011	-114,763	-114,487	-113,969	-111,361	-110,988	-110,801	-101,610	-89,425	-84,364	-79,252
Treasury Stock, Shares at Cost
Treasury Stock
Additional Paid-in Capital	94,248	93,603	92,631	91,802	90,591	88,674	87,428	86,253	84,278	82,685	81,016
Additional Paid-in Capital
Accumulated Other Comprehensive Income	-8,066	-7,842	-7,961	-8,304	-5,897	-5,310	-11,640	-11,275	-9,321	-11,036	-9,522
Accumulated Other Comprehensive Loss
Retained Earnings	121,150	116,725	118,353	125,656	103,394	90,392	97,670	89,554	85,291	71,774	71,993
Retained Earnings
Total Common Shareholders' Equity	92,801	88,203	89,014	95,661	77,201	63,238	63,143	63,407	71,308	59,544	64,720
Total Pfizer Inc. Shareholders' Equity
Minority Interests and Other	295	294	274	256	262	235	303	351	348	296	278
Equity Attributable to Noncontrolling Interests
Total Shareholders' Equity	93,096	88,497	89,288	95,916	77,462	63,473	63,447	63,758	71,656	59,840	64,998
Total Equity
Total Liabilities and Shareholders' Equity	208,731	213,396	226,501	197,205	181,476	154,229	167,594	159,422	171,797	171,615	167,381
Total Liabilities and Equity